We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.1M
AUM Growth
-$17.9M
Cap. Flow
-$4.42M
Cap. Flow %
-7.61%
Top 10 Hldgs %
43.93%
Holding
340
New
63
Increased
59
Reduced
56
Closed
151

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$2.31M
2
AMGN icon
Amgen
AMGN
+$1.97M
3
IBB icon
iShares Biotechnology ETF
IBB
+$1.79M
4
TSRO
TESARO, Inc.
TSRO
+$1.56M
5
CLX icon
Clorox
CLX
+$1.3M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$5.02M
2
AKBA icon
Akebia Therapeutics
AKBA
+$3.63M
3
FL
Foot Locker
FL
+$2.12M
4
GIS icon
General Mills
GIS
+$2.03M
5
LULU icon
lululemon athletica
LULU
+$1.38M

Sector Composition

Rank Sector Weight
1 Healthcare 37.51%
2 Consumer Staples 17.11%
3 Consumer Discretionary 2.69%
4 Communication Services 1.36%
5 Materials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAIN icon
151
PUT
Hain Celestial
HAIN
$50.6M
$13K 0.02%
21,000
+4,000
+24% +$144K
KHC icon
152
CALL
Kraft Heinz
KHC
$30.7B
$13K 0.02%
45,100
-31,300
-41% -$2.84M
POT
153
CALL
DELISTED
Potash Corp Of Saskatchewan
POT
$13K 0.02%
91,300
+81,300
+813% +$1.35M
CELG
154
PUT
DELISTED
Celgene Corp
CELG
$13K 0.02%
5,000
-38,500
-89% -$4.72M
WFM
155
CALL
DELISTED
Whole Foods Market Inc
WFM
$12K 0.02%
+21,400
New +$779K
MDLZ icon
156
CALL
Mondelez International
MDLZ
$78.3B
$11K 0.02%
46,500
-31,700
-41% -$1.43M
PALI icon
157
PUT
Palisade Bio
PALI
$342M
– –
0
– –
TXT icon
158
PUT
Textron
TXT
$15.9B
$11K 0.02%
+6,300
New +$296K
CA
159
CALL
DELISTED
CA, Inc.
CA
$11K 0.02%
+10,000
New +$324K
DBI icon
160
CALL
Designer Brands
DBI
$290M
$10K 0.02%
+20,000
New +$373K
NIHD
161
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$10K 0.02%
12,500
-32,500
-72% -$24.8K
K
162
CALL
DELISTED
Kellanova
K
$9K 0.02%
49,097
-41,428
-46% -$2.79M
KR icon
163
CALL
Kroger
KR
$36B
$9K 0.02%
+25,000
New +$709K
RAD
164
CALL
DELISTED
Rite Aid Corporation
RAD
$8K 0.01%
+1,525
New +$115K
MNK
165
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$8K 0.01%
+7,700
New +$338K
BKD icon
166
CALL
Brookdale Senior Living
BKD
$3.58B
$7K 0.01%
+18,700
New +$258K
BUD icon
167
CALL
AB InBev
BUD
$156B
$7K 0.01%
+5,000
New +$573K
DVAX
168
PUT
DELISTED
Dynavax Technologies
DVAX
$7K 0.01%
83,600
+68,400
+450% +$444K
HAIN icon
169
CALL
Hain Celestial
HAIN
$50.6M
$7K 0.01%
+5,900
New +$213K
COST icon
170
CALL
Costco
COST
$417B
$6K 0.01%
+10,000
New +$1.72M
KO icon
171
PUT
Coca-Cola
KO
$351B
$6K 0.01%
17,000
-43,500
-72% -$1.92M
VZ icon
172
CALL
Verizon
VZ
$182B
$6K 0.01%
17,500
– –
ZYNE
173
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$6K 0.01%
+3,000
New +$59.6K
KATE
174
CALL
DELISTED
Kate Spade & Company
KATE
$6K 0.01%
50,400
+30,000
+147% +$553K
KATE
175
DELISTED
Kate Spade & Company
KATE
$6K 0.01%
300
– –
5 6
7
8 9

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q2 2017 Portfolio in Review

As of Q2 2017, FT Options held 340 positions worth $58.1M, down 24% from $76M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $4.42M in Q2 2017, closing 151 positions and reducing 56 holdings. Its most notable exit was Foot Locker, an estimated $2.12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, FT Options opened a new position in Amgen worth $2.08M.

  • FT Options's largest Q2 2017 buy was Amgen: 12,082 shares worth $2.08M.
  • FT Options added most to Clovis Oncology, Inc. in Q2 2017, an estimated $2.31M increase.
  • FT Options's biggest Q2 2017 reduction was Abbott, cutting an estimated $5.02M.
  • FT Options fully exited Foot Locker in Q2 2017, selling an estimated $2.12M.
  • FT Options's ten largest holdings make up 44% of its $58.1M portfolio in Q2 2017.
  • FT Options opened 63 new positions and closed 151 in Q2 2017.
  • FT Options's portfolio value fell 24% quarter-over-quarter to $58.1M.

Based on FT Options's 13F filing for Q2 2017, filed 11 Aug 2017.